{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T07:28:25Z","timestamp":1666682905106},"reference-count":33,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2019.8406","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T13:54:08Z","timestamp":1577800448000},"source":"Crossref","is-referenced-by-count":2,"title":["Suppression of \u03b1\u2011methylacyl\u2011coenzyme A racemase by miR200c inhibits prostate adenocarcinoma cell proliferation and migration"],"prefix":"10.3892","author":[{"given":"Hanbing","family":"Xie","sequence":"first","affiliation":[{"name":"Pathology Department and State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan 610041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Nie","sequence":"additional","affiliation":[{"name":"Pathology Department and State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan 610041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengni","family":"Zhang","sequence":"additional","affiliation":[{"name":"Pathology Department and State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan 610041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengzheng","family":"Su","sequence":"additional","affiliation":[{"name":"Pathology Department and State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan 610041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueqin","family":"Chen","sequence":"additional","affiliation":[{"name":"Pathology Department and State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan 610041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Xu","sequence":"additional","affiliation":[{"name":"Pathology Department and State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan 610041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Gong","sequence":"additional","affiliation":[{"name":"Pathology Department and State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan 610041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ni","family":"Chen","sequence":"additional","affiliation":[{"name":"Pathology Department and State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan 610041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao","family":"Zhou","sequence":"additional","affiliation":[{"name":"Pathology Department and State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, Sichuan 610041, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,12,31]]},"reference":[{"key":"key20200713005845_b1-etm-0-0-8406","doi-asserted-by":"publisher","first-page":"5997","DOI":"10.1038\/onc.2015.48","article-title":"Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential","volume":"34","author":"Knezevic","year":"2015","journal-title":"Oncogene"},{"key":"key20200713005845_b2-etm-0-0-8406","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1128\/MCB.06212-11","article-title":"MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F","volume":"32","author":"Jurmeister","year":"2012","journal-title":"Mol Cell Biol"},{"key":"key20200713005845_b3-etm-0-0-8406","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s12032-014-0428-3","article-title":"The downregulation of miR-200c\/141 promotes ZEB1\/2 expression and gastric cancer progression","volume":"32","author":"Zhou","year":"2015","journal-title":"Med Oncol"},{"key":"key20200713005845_b4-etm-0-0-8406","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/1479-5876-10-186","article-title":"Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer","volume":"10","author":"Valladares-Ayerbes","year":"2012","journal-title":"J Transl Med"},{"key":"key20200713005845_b5-etm-0-0-8406","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/SLA.0b013e3182a6909d","article-title":"Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer","volume":"259","author":"Toiyama","year":"2014","journal-title":"Ann Surg"},{"key":"key20200713005845_b6-etm-0-0-8406","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.1007\/s13277-015-3138-3","article-title":"MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer","volume":"36","author":"Gao","year":"2015","journal-title":"Tumour Biol"},{"key":"key20200713005845_b7-etm-0-0-8406","doi-asserted-by":"publisher","first-page":"12543","DOI":"10.18632\/oncotarget.3815","article-title":"miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1","volume":"6","author":"Butz","year":"2015","journal-title":"Oncotarget"},{"key":"key20200713005845_b8-etm-0-0-8406","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/pros.22968","article-title":"MiR200c targets IRS1 and suppresses prostate cancer cell growth","volume":"75","author":"Su","year":"2015","journal-title":"Prostate"},{"key":"key20200713005845_b9-etm-0-0-8406","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.ajpath.2012.08.011","article-title":"Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205","volume":"181","author":"Puhr","year":"2012","journal-title":"Am J Pathol"},{"key":"key20200713005845_b10-etm-0-0-8406","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/bcr2885","article-title":"miR-200c at the nexus of epithelial-mesenchymal transition, resistance to apoptosis, and the breast cancer stem cell phenotype","volume":"13","author":"Radisky","year":"2011","journal-title":"Breast Cancer Res"},{"key":"key20200713005845_b11-etm-0-0-8406","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3892\/etm.2017.4147","article-title":"MicroRNA-200c suppresses cell growth and metastasis by targeting Bmi-1 and E2F3 in renal cancer cells","volume":"13","author":"Qiu","year":"2017","journal-title":"Exp Ther Med"},{"key":"key20200713005845_b12-etm-0-0-8406","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.biopha.2017.01.023","article-title":"MicroRNA-200c binding to FN1 suppresses the proliferation, migration and invasion of gastric cancer cells","volume":"88","author":"Zhang","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"key20200713005845_b13-etm-0-0-8406","doi-asserted-by":"crossref","first-page":"5206","DOI":"10.18632\/oncotarget.14123","article-title":"MiR-200c is a cMyc-activated miRNA that promotes nasopharyngeal carcinoma by downregulating PTEN","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"key20200713005845_b14-etm-0-0-8406","first-page":"5665","article-title":"MicroRNA200c suppresses urothelial carcinoma invasiveness by targeting FSCN1","volume":"10","author":"Zhang","year":"2017","journal-title":"Int J Clin Exp Pathol"},{"key":"key20200713005845_b15-etm-0-0-8406","doi-asserted-by":"publisher","first-page":"5562","DOI":"10.1158\/0008-5472.CAN-16-0140","article-title":"miR-9 and miR-200 regulate PDGFR\u03b2-mediated endothelial differentiation of tumor cells in triple-negative breast cancer","volume":"76","author":"D'Ippolito","year":"2016","journal-title":"Cancer Res"},{"key":"key20200713005845_b16-etm-0-0-8406","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.cell.2009.07.011","article-title":"Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells","volume":"138","author":"Shimono","year":"2009","journal-title":"Cell"},{"key":"key20200713005845_b17-etm-0-0-8406","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/ncb1722","article-title":"The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1","volume":"10","author":"Gregory","year":"2008","journal-title":"Nat Cell Biol"},{"key":"key20200713005845_b18-etm-0-0-8406","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-1-61779-083-6_6","article-title":"Detection of microRNAs in prostate cancer cells by microRNA array","volume":"732","author":"Tang","year":"2011","journal-title":"Methods Mol Biol"},{"key":"key20200713005845_b19-etm-0-0-8406","first-page":"7365","article-title":"Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer","volume":"63","author":"Zha","year":"2003","journal-title":"Cancer Res"},{"key":"key20200713005845_b20-etm-0-0-8406","first-page":"EC10","article-title":"Expression of alpha methylacyl CoA racemase (AMACR) in gastric adenocarcinoma and its correlation with helicobacter pylori infection","volume":"10","author":"Jindal","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"key20200713005845_b21-etm-0-0-8406","doi-asserted-by":"publisher","first-page":"e1000334","DOI":"10.1371\/journal.pgen.1000334","article-title":"Deletion hotspots in AMACR promoter CpG island are cis-regulatory elements controlling the gene expression in the colon","volume":"5","author":"Zhang","year":"2009","journal-title":"PLoS Genet"},{"key":"key20200713005845_b22-etm-0-0-8406","doi-asserted-by":"crossref","first-page":"11588","DOI":"10.18632\/oncotarget.2597","article-title":"AMACR amplification and overexpression in primary imatinib-na\u00efve gastrointestinal stromal tumors: A driver of cell proliferation indicating adverse prognosis","volume":"5","author":"Li","year":"2014","journal-title":"Oncotarget"},{"key":"key20200713005845_b23-etm-0-0-8406","doi-asserted-by":"publisher","first-page":"6141","DOI":"10.1158\/1078-0432.CCR-14-1182","article-title":"AMACR amplification in myxofibrosarcomas: A mechanism of overexpression that promotes cell proliferation with therapeutic relevance","volume":"20","author":"Li","year":"2014","journal-title":"Clin Cancer Res"},{"key":"key20200713005845_b24-etm-0-0-8406","doi-asserted-by":"publisher","first-page":"28891","DOI":"10.18632\/oncotarget.8499","article-title":"Brachyury as a potential modulator of androgen receptor activity and a key player in therapy resistance in prostate cancer","volume":"7","author":"Pinto","year":"2016","journal-title":"Oncotarget"},{"key":"key20200713005845_b25-etm-0-0-8406","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s11033-007-9196-x","article-title":"Molecular cloning and preliminary analysis of the human alpha-methylacyl-CoA racemase promoter","volume":"36","author":"Chen","year":"2009","journal-title":"Mol Biol Rep"},{"key":"key20200713005845_b26-etm-0-0-8406","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1158\/1541-7786.MCR-04-0178","article-title":"A nonclassic CCAAT enhancer element binding protein binding site contributes to alpha-methylacyl-CoA racemase expression in prostate cancer","volume":"3","author":"Zha","year":"2005","journal-title":"Mol Cancer Res"},{"key":"key20200713005845_b27-etm-0-0-8406","doi-asserted-by":"publisher","first-page":"10004","DOI":"10.1074\/jbc.M805997200","article-title":"BCL-xL is a target gene regulated by hypoxia-inducible factor-1{alpha}","volume":"284","author":"Chen","year":"2009","journal-title":"J Biol Chem"},{"key":"key20200713005845_b28-etm-0-0-8406","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200713005845_b29-etm-0-0-8406","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1158\/0008-5472.CAN-09-3718","article-title":"MicroRNA145 targets BNIP3 and suppresses prostate cancer progression","volume":"70","author":"Chen","year":"2010","journal-title":"Cancer Res"},{"key":"key20200713005845_b30-etm-0-0-8406","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/S0022-2275(20)31983-0","article-title":"Subcellular localization and physiological role of alpha-methylacyl-CoA racemase","volume":"41","author":"Ferdinandusse","year":"2000","journal-title":"J Lipid Res"},{"key":"key20200713005845_b31-etm-0-0-8406","first-page":"775","article-title":"Branched fatty acids in dairy and beef products markedly enhance alpha-methylacyl-CoA racemase expression in prostate cancer cells in vitro","volume":"12","author":"Mobley","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key20200713005845_b32-etm-0-0-8406","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1471-2407-14-82","article-title":"Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs","volume":"14","author":"Erdmann","year":"2014","journal-title":"BMC Cancer"},{"key":"key20200713005845_b33-etm-0-0-8406","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.2174\/1871520614666140327152607","article-title":"Trifluoroibuprofen inhibits \u03b1-methylacyl coenzyme A racemase (AMACR\/P504S), reduces cancer cell proliferation and inhibits in vivo tumor growth in aggressive prostate cancer models","volume":"14","author":"Festuccia","year":"2014","journal-title":"Anticancer Agents Med Chem"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T16:01:25Z","timestamp":1613318485000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2019.8406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,31]]},"references-count":33,"URL":"https:\/\/doi.org\/10.3892\/etm.2019.8406","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,31]]}}}